The use of neoadjuvant chemotherapy in patients with pancreatic cancer undergoing pancreatic resection was found to be associated with lower postoperative hospital readmission.
The use of neoadjuvant chemotherapy in patients with pancreatic cancer undergoing pancreatic resection was found to be associated with lower postoperative hospital readmission.